Table 3 Effect of treatment on metabolic parameters

From: Role of angiotensin II in plasma PAI-1 changes induced by imidapril or candesartan in hypertensive patients with metabolic syndrome

Parameters

Imidapril (n=40)

Candesartan (n=39)

FPG (mg dl−1)

 Baseline

92.2±8.3

91.9±8.1

 Week 16

90.8±8.2

90.9±7.9

FPI (μIU ml−1)

 Baseline

14.4±3.8

14.2±3.9

 Week 16

13.8±3.5

13.9±3.6

TG (mg dl−1)

 Baseline

169.5±33.1

171.4±33.7

 Week 16

159.5±31.8

165.3±32.5

HDL-C (mg dl−1)

 Baseline

42.6±5.5

42.4±5.3

 Week 16

42.9±5.4

42.5±5.5

TC (mg dl−1)

 Baseline

189.8±13.6

191.2±13.6

 Week 16

186.2±13.5

189.9±13.7

  1. Abbreviations: FPG, fasting plasma glucose; FPI, fasting plasma insulin; HDL-C, high-density lipoprotein cholesterol; TC, total cholesterol; TG, triglycerides.
  2. P not significant.
Back to article page